EU research projects

IDF Europe welcomes the opportunity to take an active role in EU-funded research and other initiatives that aim at improving the health of European citizens, as these contribute to finding new treatments for diabetes and improving the lives of people living with this condition.

Developed within the EU Seventh Framework Programme (FP7) and Horizon 2020 research and innovation programme, these projects encourage the development and validation of new therapies, methods for health promotion and prevention, as well as sustainable and efficient healthcare systems. IDF Europe is currently involved in the following projects: Recognised, ISLET, Trials@Home, and Sports & Diabetes. Past projects in which IDF Europe involved were CarpeDiabFeel4diabetes, EConda, EUROCONDOR, Manage Care, JA-CHRODIS, EuRhythdia, and ePredice

  • Sport&Diabetes

    Sport&Diabetes, a project co-founded by the Erasmus+ programme of the European Union, aims to create a publication that will address the concerns of people living with diabetes, their carers and relatives, coaches, sports and gym teachers regarding engaging in sporting activities when living with diabetes. The project will also aim to raise awareness of the link between physical activity and diabetes management using the networks of project partners – TSV Bayer Leverkusen (Germany), International Diabetes Federation Europe (Belgium), HAŠK Mladost (Croatia), Olympiakos (Greece), Lazio Volley (Italy) and Wiener Sport Club (Austria).


    Type 1 diabetes (T1D) represents a huge personal and societal challenge. According to the IDF Atlas, 9th edition, 1.1 million children and adolescents (0-19 years of age) live with T1D in the world including 296,500 in Europe. The number of newly-diagnosed children and adolescents in Europe each year is estimated to be around 31,000. Type 1 diabetes is an auto-immune condition in which the body’s immune system attacks the insulin-producing beta cells of the pancreas, as a result of which the body produces little or no insulin. Type 1 diabetes most frequently develops in children and young adults and is one of the most common chronic diseases in childhood, although it can occur at any age. People living with T1D require daily insulin injections, without which they would die.

  • Recognised

    IDF Europe is part of the four-year RECOGNISED project that will study the biological mechanisms that cause structural and functional alterations in the retina in people with type 2 diabetes, to determine whether these same pathways play a role in the events observed in the brain during the development of cognitive impairment and dementia. Importantly, RECOGNISED will reveal whether evaluating the retina, easily accessible with current non-invasive technologies, could help in identifying earlier cognitive impairment in people with type 2 diabetes, so that appropriate support can be given.

© 2021 International Diabetes Federation Disclaimer Privacy policy